PRO SUNFUN participated Taiwan Design Fair

If a goal requires a commitment of 20 to 25 years and carries no guarantee of success, are you still willing to pursue it?

Navigating an unfamiliar path can be perplexing for individuals, and it poses an even greater challenge for companies.

R&D embodies a company's spirit of innovation, but how much are companies prepared to invest in it?

R&D is essentially an investment, and like any investment, it entails assessing both the return on investment and the time it takes.

Despite the inherent risks, when R&D ventures into unpredictable and hazardous territory,

most operators don't believe they would take such an immeasurable risk for the sake of P&O operations.

"It all boils down to summoning the courage to confront the unknown!

To venture into uncharted territory, to gaze into the future, and determine if we can find the good,"

proclaimed Ray Dai, Special Assistant to the Chairman of Pro Sunfun.

Since its inception in 1999, our company has been steadfastly dedicated to researching and developing "peptide sequences," which are substantial biological molecules composed of several amino acids.

While proteins are significant biological molecules consisting of numerous amino acids, peptides are intermediate in size, composed of a smaller number of amino acids. Due to their exceptionally small size, at least less than 1/50th the size of a human cell, they are easily absorbed by the human body.

Hence, they are highly efficient when absorbed by the human body. Consequently, Pro Sunfun has committed years to researching and developing this stable, safe, and effective product.

Following years of research, Pro Sunfun has formulated a medication that aids in diabetic wound healing and collagen production to ensure both stability and functionality.

To guarantee the drug's stability and effectiveness, we are currently conducting ongoing tests within the medical system.

The journey of researching and developing specific sequence peptides is akin to an uncharted path,

resembling navigation through an expansive universe without any boundaries.

It was only in 2021 that Pro Sunfun finally acquired its initial pass and is progressing toward the objective of obtaining drug certification.

Simultaneously, we are strategizing the establishment of our own brand and the promotion of new medications.

In the future, we eagerly anticipate entering the To B market, which, if successful, may mark a significant milestone in human medical care.